Nick Giannoukakis

Nick Giannoukakis

UNVERIFIED PROFILE

Are you Nick Giannoukakis?   Register this Author

Register author
Nick Giannoukakis

Nick Giannoukakis

Publications by authors named "Nick Giannoukakis"

Are you Nick Giannoukakis?   Register this Author

61Publications

856Reads

46Profile Views

Co-Stimulation-Impaired Bone Marrow-Derived Dendritic Cells Prevent Dextran Sodium Sulfate-Induced Colitis in Mice.

Front Immunol 2018 3;9:894. Epub 2018 May 3.

Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.00894DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943510PMC
July 2019

Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy.

Front Immunol 2019 6;10:148. Epub 2019 Feb 6.

Allegheny Health Network Institute of Cellular Therapeutics, Allegheny General Hospital, Pittsburgh, PA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.00148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372505PMC
February 2019

Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease.

Front Immunol 2017 12;8:1279. Epub 2017 Oct 12.

Allegheny Health Network Institute of Cellular Therapeutics, Allegheny General Hospital, Pittsburgh, PA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2017.01279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643419PMC
October 2017

Generation of antigen-specific Foxp3+ regulatory T-cells in vivo following administration of diabetes-reversing tolerogenic microspheres does not require provision of antigen in the formulation.

Clin Immunol 2015 Sep 12;160(1):103-23. Epub 2015 Mar 12.

Institute of Cellular Therapeutics, 11th Floor South Tower, Allegheny Health Network, 320 East North Avenue, Pittsburgh, PA, 15212, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2015.03.004DOI Listing
September 2015

A brief glimpse over the horizon for type 1 diabetes nanotherapeutics.

Clin Immunol 2015 Sep 25;160(1):36-45. Epub 2015 Mar 25.

Institute of Cellular Therapeutics, 11th Floor South Tower, Allegheny Health Network, 320 East North Avenue, Pittsburgh, PA 15212, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216616150011
Publisher Site
http://dx.doi.org/10.1016/j.clim.2015.03.016DOI Listing
September 2015

Nanotherapeutics for autoimmunity becomes mainstream.

Clin Immunol 2015 Sep 11;160(1):1-2. Epub 2015 Jul 11.

Division of Pharmaceutical Sciences, Mylan School of Pharmacy, Duquesne University, Pittsburgh, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2015.07.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554816PMC
September 2015

Cellular therapies based on stem cells and their insulin-producing surrogates: a 2015 reality check.

Pediatr Diabetes 2015 May 5;16(3):151-63. Epub 2015 Feb 5.

Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pedi.12259DOI Listing
May 2015

Antibody-functionalized peptidic membranes for neutralization of allogeneic skin antigen-presenting cells.

Acta Biomater 2014 Nov 10;10(11):4759-4767. Epub 2014 Aug 10.

Division of Pharmaceutical Sciences, Duquesne University, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.actbio.2014.08.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186902PMC
November 2014

Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD mice.

PLoS One 2014 17;9(1):e83575. Epub 2014 Jan 17.

Division of Immunogenetics, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America ; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0083575PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894962PMC
September 2014

Evaluation of ranirestat for the treatment of diabetic neuropathy.

Expert Opin Drug Metab Toxicol 2014 Jul 30;10(7):1051-9. Epub 2014 Apr 30.

University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, Department of Pathology and Immunology , 4401 Penn Avenue, Pittsburgh, PA 15224 , USA +1 412 692 8127 (voice) ; +1 412 692 7515 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2014.916277DOI Listing
July 2014

Coassembly of amphiphilic peptide EAK16-II with histidinylated analogues and implications for functionalization of β-sheet fibrils in vivo.

Biomaterials 2014 Jun 28;35(19):5196-205. Epub 2014 Mar 28.

Division of Pharmaceutical Sciences, Duquesne University, 15282 PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2014.03.009DOI Listing
June 2014

In vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetes.

Rev Diabet Stud 2012 28;9(4):348-56. Epub 2012 Dec 28.

Division of Immunogenetics, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, 4401 Penn Avenue, Pittsburgh, PA 15224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1900/RDS.2012.9.348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740702PMC
January 2014

It's time to bring dendritic cell therapy to type 1 diabetes.

Diabetes 2014 Jan;63(1):20-30

Department of Medicine, Columbia Center for Translational Immunology and Naomi Berrie Diabetes Center, Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db13-0886DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968436PMC
January 2014

Tolerogenic dendritic cells for Type 1 diabetes.

Immunotherapy 2013 Jun;5(6):569-71

Department of Pathology, University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.13.50DOI Listing
June 2013

Retaining antibodies in tumors with a self-assembling injectable system.

Mol Pharm 2013 Mar 18;10(3):1035-44. Epub 2013 Feb 18.

Division of Pharmaceutical Sciences, Duquesne University , Pittsburgh, Pennsylvania 15282, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/mp300504zDOI Listing
March 2013

Dendritic cell therapy for Type 1 diabetes suppression.

Immunotherapy 2012 Oct;4(10):1063-74

Department of Pathology, University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, Rangos Research Center, 4401 Penn Avenue, Pittsburgh, PA 15224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.12.76DOI Listing
October 2012

A role for tolerogenic dendritic cell-induced B-regulatory cells in type 1 diabetes mellitus.

Curr Opin Endocrinol Diabetes Obes 2012 Aug;19(4):279-87

Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MED.0b013e328355461bDOI Listing
August 2012

Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?

Clin Dev Immunol 2011 18;2011:432016. Epub 2011 Jul 18.

Division of Immunogenetics, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, 4401 Penn Avenue, Pittsburgh, PA 15224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/432016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139873PMC
February 2012

FoxO6 integrates insulin signaling with gluconeogenesis in the liver.

Diabetes 2011 Nov 22;60(11):2763-74. Epub 2011 Sep 22.

Division of Immunogenetics, Department of Pediatrics, Children’s Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db11-0548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198083PMC
November 2011

Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients.

Diabetes Care 2011 Sep 16;34(9):2026-32. Epub 2011 Jun 16.

Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc11-0472DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161299PMC
September 2011

Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.

Immunol Res 2011 Aug;50(2-3):130-52

Department of Pediatrics, Division of Immunogenetics, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, 4401 Penn Avenue, Pittsburgh, PA 15224, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12026-011-8206-1
Publisher Site
http://dx.doi.org/10.1007/s12026-011-8206-1DOI Listing
August 2011

A peptide-based material platform for displaying antibodies to engage T cells.

Biomaterials 2011 Jan 28;32(1):249-57. Epub 2010 Sep 28.

Division of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA 15282, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2010.08.083DOI Listing
January 2011

Drug delivery technologies for autoimmune disease.

Expert Opin Drug Deliv 2010 Nov 20;7(11):1279-89. Epub 2010 Oct 20.

University of Pittsburgh School of Medicine, Diabetes Institute, Department of Pathology, Rangos Research Center 6123, Pittsburgh, PA 15224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425247.2010.527329DOI Listing
November 2010

Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in mice.

PLoS One 2010 Aug 17;5(8):e12252. Epub 2010 Aug 17.

Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012252PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923200PMC
August 2010

FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages.

Diabetes 2009 Nov 3;58(11):2624-33. Epub 2009 Aug 3.

Division of Immunogenetics, Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db09-0232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768186PMC
November 2009

Dendritic cell-based therapy in Type 1 diabetes mellitus.

Expert Rev Clin Immunol 2009 May;5(3):325-39

University of Pittsburgh School of Medicine, Department of Pediatrics, Division of Immunogenetics, Children's Hospital of Pittsburgh, Rangos Research Center, 530 45th Street, Pittsburgh, PA 15201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/eci.09.8DOI Listing
May 2009

Renal diseases as targets of gene therapy.

Contrib Nephrol 2008 ;159:1-12

Division of Immunogenetics, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pa., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000125552DOI Listing
August 2008

A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes.

Diabetes 2008 Jun 3;57(6):1544-55. Epub 2008 Mar 3.

Diabetes Institute, Division of Immunogenetics, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db07-0507DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713034PMC
June 2008

Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyond.

Pediatr Diabetes 2008 Jun;9(3 Pt 2):4-13

Division of Immunogenetics, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-5448.2008.00401.xDOI Listing
June 2008

Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.

Pediatr Endocrinol Rev 2008 Jun;5(4):873-9

Division of Immunogenetics, Department of Pediatrics, University of Pittsburgh School of Medicine, PA, USA.

View Article

Download full-text PDF

Source
June 2008

Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications.

Expert Opin Investig Drugs 2008 Apr;17(4):575-81

University of Pittsburgh School of Medicine, Department of Pathology and Immunology, Diabetes Institute, Rangos Research Center, 3460 Fifth Avenue, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/13543784.17.4.57
Publisher Site
http://dx.doi.org/10.1517/13543784.17.4.575 DOI Listing
April 2008

Induction of immune tolerance to facilitate beta cell regeneration in type 1 diabetes.

Adv Drug Deliv Rev 2008 Jan 9;60(2):106-13. Epub 2007 Oct 9.

Division of Immunogenetics, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.addr.2007.08.032DOI Listing
January 2008

BIM-51077, a dipeptidyl peptidase-IV-resistant glucagon-like peptide-1 analog.

Curr Opin Investig Drugs 2007 Oct;8(10):842-8

University of Pittsburgh School of Medicine, Diabetes Institute, Rangos Research Center, 3460 Fifth Avenue, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
October 2007

Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus.

Expert Opin Biol Ther 2007 Jul;7(7):951-63

Children's Hospital of Pittsburgh, Diabetes Institute, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.7.7.951 DOI Listing
July 2007

Gene therapy for type 1 diabetes: is it ready for the clinic?

Immunol Res 2006 ;36(1-3):83-9

Diabetes Institute, Children's Hospital of Pittsburgh, Pittsburgh 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/IR:36:1:83DOI Listing
May 2007

Drug evaluation: ranirestat--an aldose reductase inhibitor for the potential treatment of diabetic complications.

Curr Opin Investig Drugs 2006 Oct;7(10):916-23

University of Pittsburgh School of Medicine, Diabetes Institute, 3460 Fifth Avenue, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
October 2006

Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes.

Pancreas 2006 Apr;32(3):231-43

Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mpa.0000203961.16630.2fDOI Listing
April 2006

Gene therapy for type 1 diabetes.

Am J Ther 2005 Nov-Dec;12(6):512-28

Diabetes Institute, Pediatric Research Section, Children's Hospital of Pittsburgh and University of Pittsburgh, Rangos Research Center, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
January 2006

Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.

Diabetes 2006 Jan;55(1):158-70

Department of Pathology, University of Pittsburgh School of Medicine, Diabetes Institute, Rangos Research Center, 3460 Fifth Avenue, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
January 2006

Gene therapy for type 1 diabetes: a proposal to move to the next level.

Curr Opin Mol Ther 2005 Oct;7(5):467-75

University of Pittsburgh School of Medicine, Department of Pathology, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
October 2005

DiaPep277 (DeveloGen).

Curr Opin Investig Drugs 2005 Oct;6(10):1043-50

University of Pittsburgh School of Medicine, Diabetes Institute, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
October 2005

Footer: a quantitative comparative genomics method for efficient recognition of cis-regulatory elements.

Genome Res 2005 Jun;15(6):840-7

Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15621, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/gr.2952005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1142474PMC
June 2005

Pyridoxamine (BioStratum).

Curr Opin Investig Drugs 2005 Apr;6(4):410-8

University of Pittsburgh School of Medicine, Diabetes Institute, 3460 Fifth Avenue, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
April 2005

Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells.

J Immunol 2004 Oct;173(7):4331-41

Diabetes Institute, Department of Pediatrics, University of Pittsburgh School of Medicine, PA 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.173.7.4331DOI Listing
October 2004

Current status and prospects for gene and cell therapeutics for type 1 diabetes mellitus.

Rev Endocr Metab Disord 2003 Dec;4(4):369-80

Department of Pathology and Diabetes Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
December 2003

Fidarestat. Sanwa Kagaku/NC Curex/Sankyo.

Curr Opin Investig Drugs 2003 Oct;4(10):1233-9

University of Pittsburgh School of Medicine, Diabetes Institute, 3460 Fifth Avenue, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
October 2003

CJC-1131. ConjuChem.

Curr Opin Investig Drugs 2003 Oct;4(10):1245-9

University of Pittsburgh School of Medicine, Diabetes Institute, 3460 Fifth Avenue, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
October 2003

Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity.

Diabetes 2003 Aug;52(8):1976-85

Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/diabetes.52.8.1976DOI Listing
August 2003

Gene therapy technology applied to disorders of glucose metabolism: promise, achievements, and prospects.

Biotechniques 2003 Jul;35(1):122-45

University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2144/03351rv01DOI Listing
July 2003

Exenatide. Amylin/Eli Lilly.

Curr Opin Investig Drugs 2003 Apr;4(4):459-65

University of Pittsburgh School of Medicine, Diabetes Institute, 3460 Fifth Avenue, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
April 2003

Gene and cell therapies for diabetes mellitus: strategies and clinical potential.

BioDrugs 2002 ;16(3):149-73

Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00063030-200216030-00001DOI Listing
February 2003

NBI-6024 (Neurocrine Biosciences).

IDrugs 2002 Dec;5(12):1162-7

Diabetes Institute University of Pittsburgh School of Medicine, 3460 Fifth Avenue, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
December 2002

Islet/pancreas transplantation: challenges for pediatrics.

Pediatr Diabetes 2002 Dec;3(4):210-23

Diabetes Institute, Rangos Research Center, Children's Hospital of Pittsburgh, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1399-5448.2002.30408.xDOI Listing
December 2002

Immunosuppressive effects of glucosamine.

J Biol Chem 2002 Oct 9;277(42):39343-9. Epub 2002 Aug 9.

Department of Surgery, T. E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M204924200DOI Listing
October 2002

Gene therapy strategies to prevent autoimmune disorders.

Curr Gene Ther 2002 Sep;2(3):341-54

Department of Pediatrics, Division of Immunogenetics, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
September 2002

Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and prevention.

Curr Opin Investig Drugs 2002 May;3(5):735-51

Department of Pathology, University of Pittsburgh School of Medicine, PA 15213, USA.

View Article

Download full-text PDF

Source
May 2002

Cellular environment and freedom of gene expression.

Nat Immunol 2002 Apr;3(4):335; author reply 336

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni0402-335aDOI Listing
April 2002